United States · Platforms & data · MarketBeat

Zimmer Biomet (NYSE:ZBH) Given New $117.00 Price Target at Citigroup

Published by MarketBeat · United States 1 d ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

Citigroup raised their price objective on shares of Zimmer Biomet from $99.00 to $117.00 and gave the company a "neutral" rating in a research note on Thursday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Better Stock Split to Buy: Meta Platforms vs. Sandisk

Investing.com

Martine Rothblatt, United Therapeutics CEO, sells $4.3M in shares

Seeking Alpha

Telus targets $900M annualized cash savings exiting 2028 while projecting $500M AI infrastructure revenue over 3 years

MarketWatch

‘I have no financial safety net’: I’m 66, rely on Social Security and have just $500 in savings. What hope do I have?

CNBC

Nasdaq drops into correction territory — here’s what typically happens next

Yahoo Finance